Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer.

导出 OA

翻译打印收藏纠错

作者： Satoshi,Tamada ^[1] ; Taro,Iguchi ^[1] ; Minoru,Kato ^[1] ; Jumpei,Asakawa ^[1] ; Kazuaki,Kita ^[1] ; Sayaka,Yasuda ^[1] ; Takeshi,Yamasaki ^[1] ; Yudai,Matsuoka ^[2] ; Kazuyuki,Yamaguchi ^[2] ; Kentaro,Matsumura ^[2] ; Ishun,Go ^[2] ; Tetsuji,Ohmachi ^[2] ; Tatsuya,Nakatani ^[1]

作者单位： Department of Urology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan. ^[1] Department of Urology, Bell Land General Hospital, Naka-ku, Sakai City, Osaka 599-8247, Japan. ^[2]

关键词 castration-resistant prostate cancer combined androgen blockade hormone-sensitive prostate cancer progression survival

DOI 10.18632/oncotarget.26426

PMID 30651928

发布时间 2024-05-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交